Drugs giant Pfizer to axe 500 jobs at Kent site
The company said the move is part of previously announced efforts to slash 3.5 billion dollars (£2.8 billion) worth of costs across the firm.
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Pharmaceutical giant Pfizer is to cut around 500 jobs at its site in Sandwich, Kent.
The company said the move is part of previously announced efforts to slash 3.5 billion dollars (£2.8 billion) worth of costs across the firm.
It said it plans to stop its pharmaceutical sciences small molecule (PSSM) operations at the site, which employs around 940 people.
Sky News reported that the roles will be moved to India and the United States.
The company will see other operations continue at the Kent location “with a different size”, a spokeswoman said.
Last month, Pfizer heavily cut its revenue forecasts in the face of lower-than-expected sales of Covid-19 vaccines and treatment.
The spokeswoman for Pfizer said: “We are proud of our heritage of breakthrough science in the UK and we will retain a scientific presence in the UK including at our Discovery Park location in Sandwich.
“These proposals are now in consultation with the affected colleagues.
“All job-related decisions will be made with transparency, respect, and in compliance with all applicable laws.
“More information around this global programme will be shared over the coming months and as part of the full-year guidance for 2024.”